Paige Meizlik

Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports

Michelle Petri, Helain J. Landy, Megan E. B. Clowse et al. · Annals of the Rheumatic Diseases · 2022 · 38 citations · Full text

Medicine, Immunology, Obstetrics +16

Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry

Patricia Juliao, Keele Wurst, Jeanne M. Pimenta et al. · Birth Defects Research · 2022 · 33 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +15

Long-term open-label continuation study of the safety and efficacy of belimumab for up to 7 years in patients with systemic lupus erythematosus from Japan and South Korea

Yoshiya Tanaka, Sang‐Cheol Bae, Damon Bass et al. · RMD Open · 2021 · 22 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial data

Daniel J. Wallace, Tatsuya Atsumi, Mark Daniels et al. · Lupus · 2022 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years

Fengchun Zhang, Jie Zheng, Yang Li et al. · RMD Open · 2022 · 17 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17